Astria Therapeutics Inc (209A.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
At close: 08:37AM CEST
| Previous close | 1.0660 |
| Open | 1.0660 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 1.0660 - 1.0660 |
| 52-week range | 1.0660 - 1.0660 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
We're Not Very Worried About Astria Therapeutics' (NASDAQ:ATXS) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- GuruFocus.com
Chief Medical Officer Christopher Morabito Sells 10,000 Shares of Astria Therapeutics Inc (ATXS)
Astria Therapeutics Inc (NASDAQ:ATXS), a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat debilitating diseases, has reported an insider sale according to a recent SEC filing.
- Simply Wall St.
Astria Therapeutics, Inc. (NASDAQ:ATXS) is favoured by institutional owners who hold 53% of the company
Key Insights Significantly high institutional ownership implies Astria Therapeutics' stock price is sensitive to their...
© 2024 Yahoo. All rights reserved.